Skip to content

Tuina for fronzen shoulder in middle-aged and elderly: randomized controlled trial

Tuina for fronzen shoulder in middle-aged and elderly: randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067153
Enrollment
Unknown
Registered
2022-12-28
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fronzen shoulder

Interventions

experimental group :Tuina theray

Sponsors

Sichuan Academy of Medical Sciences·Sichuan Provincial People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with shoulder pain, often manifested as anteromedial extension of the shoulder distal to the biceps region, or lateral extension of the shoulder to the deltoid region, or limited shoulder movement; 2.Aged between 50 and 70 years old; 3.The course of the disease is more than 3 months; 4.Be able to use Chinese to communicate and fill in scales;

Exclusion criteria

Exclusion criteria: 1.Patients with rheumatoid or rheumatoid arthritis of the shoulder, shoulder joint trauma, shoulder fracture, shoulder joint tumor, and metal inserts in the shoulder joint; 2.Those who suffer from severe cardiovascular and cerebrovascular diseases, immune deficiencies, mental disorders, blood system diseases, limb motor dysfunction or cannot adhere to treatment for various reasons; 3.Patients with serious infectious diseases (such as scarlet fever, chickenpox), bleeding diseases (such as bleeding, local skin with any form of malignant tumor), skin problems (such as burns, severe skin damage, and skin infections), or any other serious diseases (such as fractures, hemiplegia).

Design outcomes

Primary

MeasureTime frame
pain;

Secondary

MeasureTime frame
Joint range of motion;motor function of upper limbs;quality of life;

Countries

China

Contacts

Public ContactXiaorong Mao

Sichuan Academy of Medical Sciences·Sichuan Provincial People’s Hospital

449696256@qq.com+8617708130985

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026